Malaysian Family Physician, Год журнала: 2024, Номер 19, С. 62 - 62
Опубликована: Ноя. 11, 2024
Язык: Английский
Headache The Journal of Head and Face Pain, Год журнала: 2025, Номер unknown
Опубликована: Фев. 10, 2025
To analyze headache and migraine dynamics around severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Headache is a common symptom of SARS-CoV-2 infection, which caused the disease 2019 (COVID-19) pandemic. However, daily changes in patterns patients with during infection are unclear. This study post hoc retrospective documented COVID-19 diagnoses diaries from large prospective cohort that consecutively enrolls eligible patients. Patients' characteristics, patterns, vaccination data were retrieved. Change points or rates this identified 28 days before (day -28) to after 28) We calculated compared weekly individual pre-infection, post-infection periods based on change points. further categorized into those increased without investigate if vaccinations affected by comparing pre- days. A total 463 patients, 370 (79.9%) females, an age (mean ± standard deviation) 41.5 11.9 years, enrolled. 26,391 diary analyzed. The change-point algorithm day -4 (95% credible interval: -5.0, -1.2) 12 7.6, 17.0). For attacks, -2 -4.9, -0.8) 11 17.2). After grouping these points, we found error mean) 1.5 0.1 pre-infection 1.8 recovered 1.6 1.0 1.3 1.1 Female older than 40 had more abrupt patterns. There was no impact pattern regardless type dose intervals between last diagnosis. demonstrated among individuals escalated early stage returned baseline along systemic viral clearance.
Язык: Английский
Процитировано
0
Frontiers in Neurology, Год журнала: 2025, Номер 16
Опубликована: Март 21, 2025
Background Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, placed unprecedented pressure on public health systems due to its mortality and global panic—and later long COVID challenges. One of these symptoms, headache, often resembles migraine-like features. Migraine shares similarities with COVID-19 COVID, yet influence sex is understudied. Our primary objective was study interrelationship between migraine prevalence, while considering differences. The secondary examine how symptoms (headache, anosmia, memory, concentration problems) affect males females without migraine. Methods All analyses were conducted using Lifelines, a prospective cohort in northern Netherlands. Baseline characteristics (2006–2014), self-reported diagnoses (until 2021), questionnaires (2020–2022) collected. Logistic regression association lifetime current infections adjusting for age, sex, diet, educational attainment, activity, smoking. Descriptive sex-stratified symptoms. Results A total 150,507 individuals included, which 29,680 (19.7%) reported 120,827 (80.3%) not. 1,867 [6.3% migraine, 44.0 years (IQR 36.1–50.3)] 6,797 [5.6% 44.4 35.3–52.2)] be infected. majority consisted (77.0% those vs. 54.0% migraine). adjusted odds having 6.3% higher among (a history of) compared logistic model (OR = 1.06, 95% CI 1.01–1.12). slightly OR observed 1.08, 1.02–1.15), not apparent 1.00, 0.88–1.12). Secondary revealed that both COVID-19, particular, most frequently bothered concentration, memory problems. Individuals none diseases least bothered. Conclusions especially females, are more likely report and/or contract COVID-19. Those conditions frequently, suggesting shared vulnerability or pathophysiology. This may indicate need clinical surveillance patients recovering from
Язык: Английский
Процитировано
0
Life, Год журнала: 2024, Номер 14(11), С. 1420 - 1420
Опубликована: Ноя. 4, 2024
The COVID-19 pandemic represents a global health phenomenon that will sadly remain part of our history. It had innumerable consequences for society and people’s lives. With different mechanisms, has been pointed out as factor in the pathophysiology several secondary disorders or deterioration pre-existing conditions. Migraine is frequent disorder can be influenced by conditions, including psychologically stressful conditions infectious diseases. purpose present study to gain insight into influence on clinical characteristics patients with migraine. A self-administrable questionnaire developed, asking migraine features before after infection. One hundred two who infected at least once were included. After infection, 54 reported worsening migraine, 45 noticed no variation, 3 an improvement. 21 changed preventive therapy due loss efficacy previous one. most effective treatments this subpopulation gene-related peptide monoclonal antibodies. presented data confirm heterogeneous but new may controlling symptoms among those report disease.
Язык: Английский
Процитировано
2
Public Health, Год журнала: 2024, Номер 237, С. 299 - 306
Опубликована: Окт. 31, 2024
Язык: Английский
Процитировано
1
PLoS ONE, Год журнала: 2024, Номер 19(8), С. e0308151 - e0308151
Опубликована: Авг. 19, 2024
Diverse studies have revealed discrepant evidence concerning the causal association between Corona Virus Disease 2019 (COVID-19) and COVID-19 vaccination in relation to migraines. Investigating correlation former two factors migraines can facilitate policymakers precise formulation of comprehensive post-pandemic interventions while urging populace adopt a judicious perspective on vaccination.
Язык: Английский
Процитировано
0
Frontiers in Neurology, Год журнала: 2024, Номер 15
Опубликована: Окт. 25, 2024
Migraine is a prevalent neurological disorder characterized by recurrent attacks, leading to substantial global disease burden. Recent observational studies have reported the onset and worsening of migraine following COVID-19 infection vaccination. However, traditional study designs limitations in controlling for confounding factors, potentially resulting biased inconsistent conclusions. To address this, we applied Mendelian randomization (MR) investigate causal relationship between vaccination with migraine.
Язык: Английский
Процитировано
0
Malaysian Family Physician, Год журнала: 2024, Номер 19, С. 62 - 62
Опубликована: Ноя. 11, 2024
Язык: Английский
Процитировано
0